Irreversible electroporation (IRE) acts as an "in situ vaccine" and induces antitumor immune responses in pancreatic cancer

被引:0
|
作者
Narayanan, Jayanth Shankara [1 ]
Hayashi, Tomoko [1 ]
Miller, Aaron M. [1 ]
Schoenberger, Stephen P. [2 ]
White, Rebekah R. [1 ]
机构
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] La Jolla Inst, La Jolla, CA USA
关键词
D O I
10.1158/2326-6074.TUMIMM17-B78
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B78
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer
    Moir, J.
    White, S. A.
    French, J. J.
    Littler, P.
    Manas, D. M.
    EJSO, 2014, 40 (12): : 1598 - 1604
  • [42] Tissue Resistance Decrease during Irreversible Electroporation of Pancreatic Cancer as a Biomarker for the Adaptive Immune Response and Survival
    Timmer, Florentine E. F.
    Geboers, Bart
    Scheffer, Hester J.
    Bakker, Joyce
    Ruarus, Alette H.
    Dijkstra, Madelon
    van der Lei, Susan
    Boon, Rianne
    Nieuwenhuizen, Sanne
    van den Bemd, Bente A. T.
    Schouten, Evelien A. C.
    van den Tol, Petrousjka M.
    Puijk, Robbert S.
    Vries, Jan J. J. de
    Gruijl, Tanja D. de
    Meijerink, Martijn R.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2023, 34 (10) : 1777 - 1784.e4
  • [43] Irreversible electroporation can alter immune cell composition and enhance antigen presentation potential in pancreatic cancer
    Brock, Rebecca Michaela
    Beitel-White, Natalie
    Hendricks, Alissa Danielle
    Zeher, Allison
    Manuchehrabadi, Navid
    Davalos, Rafael, V
    Allen, Irving C.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [44] Zap! Irreversible electroporation in pancreatic cancer cells induces proinflammatory cell death and improves progression free survival
    Powar, Manali
    Imran, Khan Mohammad
    Allen, Irving C.
    Davalos, Rafael V.
    Salamah, Zaid
    Aycock, Kenneth
    Brock, Rebecca M.
    Coutermarsh-Ott, Sheryl
    Orr, Katie
    CANCER RESEARCH, 2024, 84 (06)
  • [45] Alfalfa mosaic virus nanoparticles-based in situ vaccination induces antitumor immune responses in breast cancer model
    Shahgolzari, Mehdi
    Pazhouhandeh, Maghsoud
    Milani, Morteza
    Fiering, Steven
    Khosroushahi, Ahmad Yari
    NANOMEDICINE, 2020, 16 (02) : 97 - 108
  • [46] Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings
    Niessen, C.
    Jung, E. M.
    Beyer, L.
    Pregler, B.
    Dollinger, M.
    Haimerl, M.
    Scheer, F.
    Stroszczynski, C.
    Wiggermann, P.
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2015, 61 (02) : 135 - 141
  • [47] OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives systemic antitumor immune response in a syngeneic pancreatic cancer model
    Zhang, Qi-Wei
    Guo, Xiao-Xia
    Zhou, Yu
    Wang, Qing-Bing
    Liu, Qin
    Wu, Zhi-Yuan
    Ding, Xiao-Yi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2782 - +
  • [48] Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments
    Guenther, E.
    Klein, N.
    Zapf, S.
    Weil, S.
    Schlosser, C.
    Rubinsky, B.
    Stehling, K.
    PLOS ONE, 2019, 14 (04):
  • [49] A Personalized Cancer Vaccine that Induces Synergistic Innate and Adaptive Immune Responses
    Kuen, Da-Sol
    Hong, Jihye
    Lee, Suyoung
    Koh, Choong-Hyun
    Kwak, Minkyeong
    Kim, Byung-Seok
    Jung, Mungyo
    Kim, Yoon-Joo
    Cho, Byung-Sik
    Kim, Byung-Soo
    Chung, Yeonseok
    ADVANCED MATERIALS, 2023, 35 (36)
  • [50] Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients
    Liikanen, Ilkka
    Ahtiainen, Laura
    Hirvinen, Mari L. M.
    Bramante, Simona
    Cerullo, Vincenzo
    Nokisalmi, Petri
    Hemminki, Otto
    Diaconu, Iulia
    Pesonen, Sari
    Koski, Anniina
    Kangasniemi, Lotta
    Pesonen, Saila K.
    Oksanen, Minna
    Laasonen, Leena
    Partanen, Kaarina
    Joensuu, Timo
    Zhao, Fang
    Kanerva, Anna
    Hemminki, Akseli
    MOLECULAR THERAPY, 2013, 21 (06) : 1212 - 1223